- Your cart is empty
- Continue Shopping
Retatrutide vs. Vaxia Pharma: The 2026 UK Guide to Modern Weight Loss
- Pharmacy
- Posted on
-
by Slim Trim
- 0 comments
Table of Contents
Last Medically Reviewed: March 12, 2026, by SlimTrim Clinical Team
The landscape of weight management in the UK has evolved. While 2024 was the year of the GLP-1, 2026 is the year of the Triple Agonist and Personalized Oral Maintenance. Whether you are looking for the “Next Gen” injection like Retatrutide or a gentle, localized blocker like Vaxia Pharma, understanding the science is your first step toward success.
Is Retatrutide a GLP-1?
No, Retatrutide is not just a GLP-1; it is a “Triple Agonist” (or “3-G” hormone). While older medications like Wegovy target only the GLP-1 receptor, Retatrutide targets three distinct metabolic pathways:
- GLP-1 (Glucagon-like peptide-1): Lowers appetite and blood sugar.
- GIP (Gastric inhibitory polypeptide): Enhances insulin sensitivity and fat metabolism.
- Glucagon: Increases energy expenditure and promotes fat breakdown.
This “Triple Action” is why clinical trials (TRIUMPH) show a groundbreaking weight loss average of 24% over 48 weeks, significantly higher than earlier GLP-1 monotherapies.
Is Retatrutide available in the UK?
As of early 2026, Retatrutide is currently in Phase 3 clinical trials in the UK. It is not yet available for general NHS prescription or private sale.
- Current Status: Ongoing TRIUMPH-1 and TRIUMPH-3 trials.
- Anticipated Launch: Late 2026 or early 2027, pending MHRA approval.
- Warning: Be wary of sites claiming to sell “Research Grade” Retatrutide; these are unregulated and potentially dangerous.
Vaxia Pharma 40mg: The Precision Oral Alternative
While injections are trending, many UK patients prefer Vaxia Pharma (Orlistat 40mg) because it is a localized, non-systemic treatment.
Unlike Retatrutide, which changes your brain’s hunger signals, Vaxia Pharma stays in your digestive tract to block fat absorption. The 40mg dose is specifically designed for:
- Weight Maintenance: Keeping the weight off after an injectable cycle.
- Sensitive Users: Those who want to avoid the nausea common with 120mg doses.
Side Effects: Retatrutide vs. Vaxia Pharma
| Side Effect Profile | Retatrutide (Triple Agonist) | Vaxia Pharma (Orlistat) |
| Common Effects | Nausea, Vomiting, Diarrhoea | Oily spotting, Urgent bowel movements |
| Metabolic Impact | Increased heart rate (mild), Satiety | Localized fat blockage (No CNS impact) |
| Serious Risks | Rare: Pancreatitis, Gallbladder issues | Rare: Vitamin deficiency (A, D, E, K) |
| Duration | Improves as dose titrates | Dependent on dietary fat intake |
Is Retatrutide a GLP-1?
No, Retatrutide is not just a GLP-1; it is a “Triple Agonist” (or “3-G” hormone). While older medications like Wegovy target only the GLP-1 receptor, Retatrutide targets three distinct metabolic pathways:
Can I switch from Mounjaro/Wegovy to Retatrutide?
In the future, “switching” protocols will likely be managed by specialists. Currently, Retatrutide is expected to be reserved for those who have not reached their goals on dual-agonists (Tirzepatide).
Do I need a prescription for Vaxia Pharma in the UK?
Yes. In the UK, Vaxia Pharma is a prescription-only medication (POM). At SlimTrim.uk, we provide a clinical consultation to ensure it is safe for your BMI and health history.
Does Retatrutide cause “Ozempic Face”?
“Ozempic face” is simply rapid subcutaneous fat loss in the face. Because Retatrutide causes even faster weight loss, skin elasticity support and protein-rich diets are highly recommended during treatment.
How do I stop the “Oily Spots” with Vaxia Pharma?
Follow the “Rule of 15”: Ensure your meal contains no more than 15g of fat. Vaxia Pharma only blocks the fat you eat; if you eat low-fat, there is no oil to cause side effects.
Is Retatrutide better than Tirzepatide (Mounjaro)?
Data suggests yes for total weight loss percentage, but Retatrutide may have a slightly higher rate of mild gastrointestinal side effects due to its “Triple Action” potency.
